Erja Chryssanthou

4.6k total citations · 1 hit paper
71 papers, 2.8k citations indexed

About

Erja Chryssanthou is a scholar working on Infectious Diseases, Epidemiology and Cell Biology. According to data from OpenAlex, Erja Chryssanthou has authored 71 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 46 papers in Epidemiology and 15 papers in Cell Biology. Recurrent topics in Erja Chryssanthou's work include Antifungal resistance and susceptibility (32 papers), Tuberculosis Research and Epidemiology (21 papers) and Fungal Infections and Studies (17 papers). Erja Chryssanthou is often cited by papers focused on Antifungal resistance and susceptibility (32 papers), Tuberculosis Research and Epidemiology (21 papers) and Fungal Infections and Studies (17 papers). Erja Chryssanthou collaborates with scholars based in Sweden, Spain and Denmark. Erja Chryssanthou's co-authors include Manuel Cuenca‐Estrella, David W. Denning, J. L. Rodríguez-Tudela, Francesco Barchiesi, B Petrini, Paul E. Verweij, Malcolm Richardson, Thomas Schön, Jacques Billé and J. Peter Donnelly and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Erja Chryssanthou

71 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts

2008 549 citations J. L. Rodríguez-Tudela, Maiken Cavling Arendrup et al. Clinical Microbiology and Infection profile →

Peers

Countries citing papers authored by Erja Chryssanthou

Since Specialization

Citations

This map shows the geographic impact of Erja Chryssanthou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erja Chryssanthou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erja Chryssanthou more than expected).

Fields of papers citing papers by Erja Chryssanthou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erja Chryssanthou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erja Chryssanthou. The network helps show where Erja Chryssanthou may publish in the future.

Co-authorship network of co-authors of Erja Chryssanthou

This figure shows the co-authorship network connecting the top 25 collaborators of Erja Chryssanthou. A scholar is included among the top collaborators of Erja Chryssanthou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erja Chryssanthou. Erja Chryssanthou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Rough Colony Morphology ofMycobacterium abscessusIs Associated With Cavitary Pulmonary Disease and Poor Clinical Outcome 2023 ·The Journal of Infectious Diseases ·(unknown), Gabrielle Fröberg, (unknown), Erja Chryssanthou, (unknown), (unknown), (unknown), Michael Runold, Bodil Jönsson, Thomas Schön, Lina Davies Forsman	19
2	The In vitro Activity of Carbapenems Alone and in Combination with β-lactamase Inhibitors against Difficult-to-treat Mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium Complex: A Systematic Review 2023 ·International Journal of Mycobacteriology ·(unknown), Gabrielle Fröberg, Victor Næstholt Dahl, Erja Chryssanthou, Christian G. Giske, Thomas Schön, Lina Davies Forsman	5
3	Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient 2022 ·Medical Mycology Case Reports ·Amelie Kinch, Mia Furebring, Erja Chryssanthou, Heléne Hallböök	1
4	Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill? 2021 ·Mycoses ·Siri Kurland, Elisabeth Löwdin, Mia Furebring, (unknown), Erja Chryssanthou, Pernilla Lagerbäck, Thomas Tängdén, Olof Breuer, Jan Sjölin	3
5	CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection 2020 ·Tuberculosis ·(unknown), Gabrielle Fröberg, Margarida Correia‐Neves, (unknown), (unknown), Robert Szulkin, Erja Chryssanthou, Kristian Ängeby, (unknown), Morten Rühwald, Peter Andersen, Gunilla Källenius, Judith Bruchfeld	3
6	Susceptibility testing breakpoints forMycobacterium tuberculosiscategorize isolates with resistance mutations ingyrAas susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB 2015 ·Journal of Antimicrobial Chemotherapy ·Katarina Niward, Kristian Ängeby, Erja Chryssanthou, Jakob Paues, Judith Bruchfeld, Pontus Juréen, Christian G. Giske, Gunnar Kahlmeter, Thomas Schön	12
7	The effect of K101 Nail Solution on Trichophyton rubrum and Candida albicans growth and ultrastructure 2014 ·Mycoses ·Kjell Hultenby, Erja Chryssanthou, Lena Klingspor, (unknown), (unknown), Jan Faergemann	10
8	Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact? 2013 ·Journal of Antimicrobial Chemotherapy ·Thomas Schön, Pontus Juréen, Erja Chryssanthou, Christian G. Giske, Gunnar Kahlmeter, Sven Hoffner, Kristian Ängeby	29
9	Candidaemia in Sweden: a nationwide prospective observational survey 2012 ·Clinical Microbiology and Infection ·Jan L. E. Ericsson, Erja Chryssanthou, Lena Klingspor, A. G. Johansson, Per Ljungman, Erik Svensson, Jan Sjölin	48
10	The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) EUCAST Technical Note on fluconazole. 2009 ·Clinical Microbiology and Infection ·(unknown), (unknown), (unknown), S. Arıkan, Francesco Barchiesi, J. Bille, Erja Chryssanthou, M. Cuenca‐Estrella, Éric Dannaoui, David W. Denning, W. Fegeler, Peter Gaustad, Н Н Климко, Cornelia Lass‐Flörl, Cecil P. Moore, Malcolm Richardson, A. Schmalreck, Jørgen Stenderup, Aristea Velegraki, Paul E. Verweij	12
11	Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. 2009 ·Clinical Microbiology and Infection ·(unknown), (unknown), (unknown), S. Arıkan, Francesco Barchiesi, J. Bille, Erja Chryssanthou, M. Cuenca‐Estrella, Éric Dannaoui, David W. Denning, W. Fegeler, Peter Gaustad, Cornelia Lass‐Flörl, Cecil P. Moore, Malcolm Richardson, A. Schmalreck, Aristea Velegraki, Paul E. Verweij	111
12	Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis 2009 ·Journal of Antimicrobial Chemotherapy ·Thomas Schön, Pontus Juréen, Christian G. Giske, Erja Chryssanthou, Erik Sturegård, Jim Werngren, Gunnar Kahlmeter, Sven Hoffner, Kristian Ängeby	92
13	EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts breakdown → 2008 ·Clinical Microbiology and Infection ·J. L. Rodríguez-Tudela, Maiken Cavling Arendrup, Francesco Barchiesi, Jacques Billé, Erja Chryssanthou, M. Cuenca‐Estrella, Éric Dannaoui, David W. Denning, J. Peter Donnelly, Françoise Dromer, W. Fegeler, Cornelia Lass‐Flörl, Caroline M. Moore, Malcolm Richardson, Per Sandven, Aristea Velegraki, Paul E. Verweij	549
14	Histoplasmosis in Europe: Report on an epidemiological survey from the European Confederation of Medical Mycology Working Group 2008 ·Medical Mycology ·H. R. Ashbee, (unknown), (unknown), M.A. Viviani, B. Dupont, Erja Chryssanthou, I. Surmont, A Tomsíková, (unknown), Beyza Ener, (unknown), Kathrin Tintelnot	88
15	Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) 2007 ·Clinical Microbiology and Infection ·Manuel Cuenca‐Estrella, Maiken Cavling Arendrup, Erja Chryssanthou, Éric Dannaoui, Cornelia Lass‐Flörl, Per Sandven, Aristea Velegraki, J. L. Rodríguez-Tudela	44
16	A fatal case of severe immunodeficiency associated with disseminated Merulius tremellosus infection 2005 ·Scandinavian Journal of Infectious Diseases ·Vanda Friman, Magnus Gisslén, Simo Nikkari, Jan Stenlid, Erja Chryssanthou, Björn Petrini	1
17	Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts 2003 ·Clinical Microbiology and Infection ·J. L. Rodríguez-Tudela, Francesco Barchiesi, Jacques Billé, Erja Chryssanthou, M. Cuenca-Estrella, David W. Denning, J. Peter Donnelly, B. Dupont, W. Fegeler, Christine Moore, Malcolm Richardson, Paul E. Verweij	164
18	Trends in Antifungal Susceptibility among Swedish Candida Species Bloodstream Isolates from 1994 to 1998: Comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A Reference Method 2001 ·Journal of Clinical Microbiology ·Erja Chryssanthou	45
19	[Advances in the diagnosis of mycoses. New tests detect Candida infections]. 1998 ·PubMed ·B Petrini, Bértil Christensson, Erja Chryssanthou, L. Edebo, Lennart Larsson	1
20	Candida glabrata Prosthesis Infection Following Pyelonephritis and Septicaemia 1997 ·Scandinavian Journal of Infectious Diseases ·Fariba Nayeri, Robert B. Cameron, Erja Chryssanthou, L. E. B. Johansson, (unknown)	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact